Trials / Completed
CompletedNCT02321553
Effect of Brown Rice on the Risk Factors for Metabolic Syndrome
Biological Functions of Brown Rice on Metabolic Syndrome: A Randomized Cross-over Pilot Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 7 (actual)
- Sponsor
- Tufts University · Academic / Other
- Sex
- All
- Age
- 50 Years
- Healthy volunteers
- Accepted
Summary
The purpose of the study is to determine the effect of consumption of brown rice on the risk factors of metabolic syndrome (MetS) as compared to consumption of white rice. Brown and white rice will be provided in the form of rice cakes and 100g will be consumed per day for 5 weeks each. The investigators hypothesize that brown rice will have beneficial effects as it is rich in fiber and also phytochemicals.
Detailed description
This is a 2-way cross-over, randomized, placebo controlled, pilot feasibility study to determine the effect of brown rice on the risk factors of metabolic syndrome (MetS). Eligible subjects (n = 9) with the MetS (\>50 yr, post-menopausal women and men) will be randomized to receive either brown rice cakes (100 g/d) as treatment or white rice cake as placebo during each 5-wk intervention phase with a 2-wk washout between phases. Subjects will visit Tufts Medical Center for all study visits, at the end of baseline (first 2 week run in phase) and weeks 7, 9 and 14, which will include a 12 hour fasting blood draw. Two sets of three 24 hour dietary recalls will be conducted during the intervention phases. Fasting blood samples will be analyzed for 1) oxidative stress markers (vitamin E concentrations, total antioxidant capacity, and lipid peroxidation product), 2) blood lipid profiles and 3) metabolic risk factors such as plasma glucose, insulin, inflammatory cytokines.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Brown rice | brown rice cake |
| OTHER | White rice | white rice cake |
Timeline
- Start date
- 2014-04-01
- Primary completion
- 2015-02-01
- Completion
- 2015-02-01
- First posted
- 2014-12-22
- Last updated
- 2015-05-14
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02321553. Inclusion in this directory is not an endorsement.